A phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
A phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
复制标题
CD34 细胞治疗的 II 期临床试验，旨在探索严重肢体缺血患者的终点选择和时机。
作者：
Fujita Y;Kinoshita M;Furukawa Y;Nagano T;Hashimoto H;Hirami Y;Kurimoto Y;Arakawa K;Yamazaki K;Okada Y;Katakami N;Uno E;Matsubara Y;Fukushima M;Nada A;Losordo DW;Asahara T;Okita Y;Kawamoto A
